Please Wait
Applying Filters...
menu
    • menu
    munit-sa-m-2025-04-14

    Virtual Booth

    Contact Supplier

    Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-04-14

    Virtual Booth

    Contact Supplier

    Menu

    Buntanetap

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,619,750Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Buntanetap shows promise in early Parkinson's with mild dementia
    Buntanetap shows promise in early Parkinson's with mild dementia

    09 Apr 2025

    // EXPRESSPHARMA

    https://www.expresspharma.in/buntanetap-shows-promise-in-early-parkinsons-with-mild-dementia-globaldata/

    EXPRESSPHARMA
    09 Apr 2025
    Share Share
    Annovis Announces First Patients in Phase 3 Study for Alzheimer’s
    Annovis Announces First Patients in Phase 3 Study for Alzheimer’s

    05 Feb 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/02/05/3021101/0/en/Annovis-Announces-First-Patients-Entered-into-Pivotal-Phase-3-Study-of-Buntanetap-for-Early-Alzheimer-s-Disease.html

    GLOBENEWSWIRE
    05 Feb 2025
    Share Share
    Annovis Bio Gets US Patent For TBI Treatment With Buntanetap
    Annovis Bio Gets US Patent For TBI Treatment With Buntanetap

    24 Jul 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/07/24/2917931/0/en/Annovis-Bio-Secures-U-S-Patent-for-Treatment-of-Acute-Traumatic-Brain-Injury-with-Buntanetap.html

    GLOBENEWSWIRE
    24 Jul 2024
    Share Share
    Annovis Bio FDA-Approved To Use New Buntanetap Crystal Form
    Annovis Bio FDA-Approved To Use New Buntanetap Crystal Form

    16 Jul 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/07/16/2913695/0/en/Annovis-Bio-Receives-FDA-Approval-to-Transition-to-New-Crystal-Form-of-Buntanetap.html

    GLOBENEWSWIRE
    16 Jul 2024
    Share Share
    Annovis Bio Announces New Data From Phase III Parkinson's Study
    Annovis Bio Announces New Data From Phase III Parkinson's Study

    02 Jul 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/07/02/2907365/0/en/Annovis-Bio-Announces-New-Data-from-Phase-III-Parkinson-s-Study-Highlighting-Improvements-in-Unified-Parkinson-s-Disease-Rating-Scale-MDS-UPDRS-and-Cognition-after-Treatment-with-B.html

    GLOBENEWSWIRE
    02 Jul 2024
    Share Share
    Annovis Bio Files Patent for New Composition of Matter for Buntanetap
    Annovis Bio Files Patent for New Composition of Matter for Buntanetap

    26 Jun 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/06/26/2904442/0/en/Annovis-Bio-Files-Patent-for-New-Composition-of-Matter-for-Buntanetap.html

    GLOBENEWSWIRE
    26 Jun 2024
    Share Share